# Sentinel Node in Endometrial Cancer

> **NCT04492995** · PHASE2 · UNKNOWN · sponsor: **Judit Pich Martínez** · enrollment: 70 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** injection via TUMIR of the tracer [99mTc] Tc-albumin nanocoloid-ICG (6 mCi, 4 ml)
- **DIAGNOSTIC_TEST:** injection via TUMIR of [99mTc] Tc-albumin nanocoloid (6mCi, 8ml).

## Key facts

- **NCT ID:** NCT04492995
- **Lead sponsor:** Judit Pich Martínez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-05
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04492995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04492995, "Sentinel Node in Endometrial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04492995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*